Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECIGEN, INC. Director's Dealing 2022

Jan 6, 2022

32044_dirs_2022-01-06_233c9a15-7d0b-40e0-b72b-9298e38031df.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2022-01-04

Reporting Person: Sabzevari Helen (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-01-04 Common Stock M 17667 Acquired 741110 Direct
2022-01-05 Common Stock S 1357 $3.5900 Disposed 739753 Direct
2022-01-05 Common Stock S 5603 $3.5901 Disposed 734150 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-01-04 Restricted Stock Units $ M 17667 Disposed Common Stock (17667) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

F2: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs.

F3: The RSUs were granted on January 4, 2019 and January 25, 2019 and the remaining RSUs vest on January 4, 2023.